This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Leslie A. Bruggeman: Innovator in Molecular Biology
Introduction
Leslie A. Bruggeman is a notable inventor based in Bethesda, MD, who has made significant contributions to the field of molecular biology. Her work primarily focuses on the quantification of specific messenger RNA transcripts, which are crucial for understanding various biological processes.
Latest Patents
Bruggeman holds a patent titled "Method for quantifying laminin and .beta.-actin messenger RNA." This innovative method allows for the quantification of human and murine laminin mRNA transcripts of the A, B1, and B2 chains, as well as human and murine .beta.-actin mRNA. The technique involves utilizing specific types of PCR primers and control cRNA, showcasing her expertise in molecular techniques.
Career Highlights
Bruggeman is associated with the United States of America as represented by the Department of Health. Her role in this esteemed organization highlights her commitment to advancing health-related research and innovation.
Collaborations
Throughout her career, Bruggeman has collaborated with esteemed colleagues such as Paul E. Klotman and Satoshi Horikoshi. These partnerships have likely enriched her research and contributed to her innovative approaches in the field.
Conclusion
Leslie A. Bruggeman's contributions to molecular biology through her patent and collaborations underscore her role as a significant innovator in her field. Her work continues to impact the understanding of critical biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile